From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
Ligand | Protein | DOCK Score |
---|---|---|
Reference compounds | ||
Docetaxel | P2X7 |  − 4.921 |
Positive control (Non-inhibitors) | ||
ATP (Adenosine triphosphate) | P2X7 |  − 6.476 |
BzATP (2′,3′-O-(4-benzoylbenzoyl) adenosine 5′-triphosphate) | P2X7 |  − 5.494 |
Negative control (Inhibitors) | ||
A-438079 | P2X7 |  − 4.499 |
AZ11645373 | P2X7 |  − 5.595 |
KN-62 | P2X7 |  − 4.957 |